Description
FeF® Benzalkonium Chloride Ph.Eur., USP/NF, JP
CAS No. 8001-54-5.
Consists of Benzyl (dodecyl) dimethyl ammonium chloride (approx. 65%) and Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 35%). Contains approx. 95% active ingredients.
Manufactured in accordance with the cGMP Guideline ICH Q7 for Active Pharmaceutical Ingredients. Multicompendial analyses according to the current European (Ph.Eur.), United States (USP/NF) and Japanese (JP) Pharmacopoeias.
| Packing sizes | Item no. | Product image |
|---|---|---|
| 1 kg bottle | 7800012 |  |
| 5 kg pail | 7800013 |  |
Documentation and services
Certificate of Suitability (CEP/COS)
European Drug Master File (ASMF)
DUNS for US import
GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
Certificate of Analysis (current version of pharmacopoeia)
Datasheet
Customer audits
Stability results
Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
Reach
Change Notification Statement
Pre-filled Supplier Questionnaire
Impurity profile
Description of the manufacturing process
Process flowchart
Packaging details
Quality agreements
Contact us
Corporate Headquaters
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Denmark
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact
